2024 Q2 Form 10-K Financial Statement

#000149315224014809 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $28.59M $52.00M $52.00M
YoY Change 100.77% 406.33% 24.15%
Cost Of Revenue $24.35M $38.55M $38.55M
YoY Change 139.44% 109.23%
Gross Profit $4.234M $13.45M $13.45M
YoY Change 4.08% 39.24%
Gross Profit Margin 14.81% 25.86% 25.86%
Selling, General & Admin $9.568M $28.03M $28.03M
YoY Change 10.07% 275.94% -13.69%
% of Gross Profit 225.96% 208.5% 208.5%
Research & Development $881.5K $2.150M $2.150M
YoY Change 33.37%
% of Gross Profit 20.82% 15.99% 15.99%
Depreciation & Amortization $954.7K $644.0K $700.0K
YoY Change -3.39% 99.35% -81.03%
% of Gross Profit 22.55% 4.79% 5.21%
Operating Expenses $12.52M $36.54M $44.11M
YoY Change 28.73% 137.1% -29.71%
Operating Profit -$8.288M -$23.10M -$30.67M
YoY Change 46.45% 68.06%
Interest Expense $386.7K $295.8K $696.0K
YoY Change -82.49% -189.32% -74.64%
% of Operating Profit
Other Income/Expense, Net -$3.518M -$103.5K -$971.3K
YoY Change -224.66% 623.22%
Pretax Income -$11.81M -$31.64M -$31.64M
YoY Change 201.25% 475.27% 92.89%
Income Tax -$55.10K -$55.10K
% Of Pretax Income
Net Earnings -$11.61M -$31.28M -$31.28M
YoY Change 183.59% 483.01% 116.06%
Net Earnings / Revenue -40.63% -60.16% -60.16%
Basic Earnings Per Share -$0.38 -$2.81
Diluted Earnings Per Share -$0.38 -$2.81 -$2.81
COMMON SHARES
Basic Shares Outstanding 30.32M shares 11.12M shares
Diluted Shares Outstanding 30.44M shares 11.12M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.90M $2.945M $2.945M
YoY Change 226.98% -57.01% -65.76%
Cash & Equivalents $14.54M $2.993M
Short-Term Investments
Other Short-Term Assets $3.679M $1.172M $1.172M
YoY Change 144.14% -49.79% -67.47%
Inventory
Prepaid Expenses
Receivables $27.22M $16.46M $16.46M
Other Receivables $1.275M $1.666M $1.666M
Total Short-Term Assets $46.45M $22.24M $22.24M
YoY Change 120.98% 14.07% 0.83%
LONG-TERM ASSETS
Property, Plant & Equipment $618.3K $2.465M $4.624M
YoY Change -87.61% 2098.21% 3238.63%
Goodwill $22.78M $16.30M
YoY Change
Intangibles $22.27M $18.57M
YoY Change 302.92%
Long-Term Investments $2.673M $2.673M $2.673M
YoY Change -16.16% 1.66% 1.66%
Other Assets $0.00 $293.5K $293.5K
YoY Change
Total Long-Term Assets $59.08M $42.47M $42.47M
YoY Change 7.18% 109.14% 105.8%
TOTAL ASSETS
Total Short-Term Assets $46.45M $22.24M $22.24M
Total Long-Term Assets $59.08M $42.47M $42.47M
Total Assets $105.5M $64.71M $64.71M
YoY Change 38.59% 62.57% 51.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.41M $23.49M $23.49M
YoY Change 77.17% 65.93% 83.94%
Accrued Expenses $13.84M $5.289M $5.657M
YoY Change 118.87% 64.45% 50.57%
Deferred Revenue
YoY Change
Short-Term Debt $5.285M $4.519M $4.519M
YoY Change 998.36% 476.05% 485.49%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $53.55M $36.18M $36.18M
YoY Change 59.77% 69.34% 65.76%
LONG-TERM LIABILITIES
Long-Term Debt $7.840M $8.177M $8.177M
YoY Change 109.12% 26.13% 64.09%
Other Long-Term Liabilities $1.807M $1.995M $1.995M
YoY Change
Total Long-Term Liabilities $9.648M $10.17M $10.17M
YoY Change 157.32% 56.9% 104.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.55M $36.18M $36.18M
Total Long-Term Liabilities $9.648M $10.17M $10.17M
Total Liabilities $63.19M $46.35M $46.35M
YoY Change 69.36% 66.44% 72.89%
SHAREHOLDERS EQUITY
Retained Earnings -$90.30M -$73.40M
YoY Change 74.35%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $42.34M $18.36M $18.36M
YoY Change
Total Liabilities & Shareholders Equity $105.5M $64.71M $64.71M
YoY Change 38.59% 62.57% 51.57%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$11.61M -$31.28M -$31.28M
YoY Change 183.59% 483.01% 116.06%
Depreciation, Depletion And Amortization $954.7K $644.0K $700.0K
YoY Change -3.39% 99.35% -81.03%
Cash From Operating Activities -$9.585M -$6.285M -$16.08M
YoY Change 661.25% 338.29% -20.91%
INVESTING ACTIVITIES
Capital Expenditures $1.610K $2.240K $2.239K
YoY Change -104.34% -153.85% -102.84%
Acquisitions
YoY Change
Other Investing Activities $35.50K $2.797M $14.08M
YoY Change -99.69% 4.04%
Cash From Investing Activities $33.89K $2.795M $14.07M
YoY Change -99.7% -67292.79% 4.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.80M 3.969M $3.954M
YoY Change -1609.59% 42580.11% -1310.65%
NET CHANGE
Cash From Operating Activities -9.585M -6.285M -$16.08M
Cash From Investing Activities 33.89K 2.795M $14.07M
Cash From Financing Activities 16.80M 3.969M $3.954M
Net Change In Cash 7.252M 480.0K $1.950M
YoY Change -18.92% -133.59% -127.06%
FREE CASH FLOW
Cash From Operating Activities -$9.585M -$6.285M -$16.08M
Capital Expenditures $1.610K $2.240K $2.239K
Free Cash Flow -$9.586M -$6.287M -$16.08M
YoY Change 684.51% 339.72% -20.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001714562
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001714562
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Asset Current
BusinessCombinationContingentConsiderationAssetCurrent
usd
CY2022Q4 us-gaap Investments
Investments
usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Asset Noncurrent
BusinessCombinationContingentConsiderationAssetNoncurrent
usd
CY2022Q4 us-gaap Goodwill
Goodwill
usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
usd
CY2023Q4 GAME Credit Facility Payable
CreditFacilityPayable
usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
usd
CY2022Q4 GAME Warrant Liability
WarrantLiability
usd
CY2022Q4 GAME Arbitration Reserve
ArbitrationReserve
usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2022 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2023 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2022 us-gaap Restructuring Charges
RestructuringCharges
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2022 GAME Arbitration Settlement Reserve
ArbitrationSettlementReserve
usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023 GAME Stock Issued During Period Value Impact Of Rounding Down After Exchange
StockIssuedDuringPeriodValueImpactOfRoundingDownAfterExchange
usd
CY2023 GAME Stock Issued During Period Value Issuance Of Common Shares To Settle Contingent Consideration
StockIssuedDuringPeriodValueIssuanceOfCommonSharesToSettleContingentConsideration
usd
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2022 GAME Shares Issued For Legal Settlements
SharesIssuedForLegalSettlements
usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2023 GAME Loss On Disposition Of Assets Held For Sale
LossOnDispositionOfAssetsHeldForSale
usd
CY2022 GAME Gain Loss On Settlement Of Patent Litigation
GainLossOnSettlementOfPatentLitigation
usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2022 GAME Gain Loss In Fair Value Of Arbitration Reserve
GainLossInFairValueOfArbitrationReserve
usd
CY2023 GAME Gain Loss In Provision For Reclamation Deposit
GainLossInProvisionForReclamationDeposit
usd
CY2022 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2023 us-gaap Other Noncash Expense
OtherNoncashExpense
usd
CY2022 GAME Increase Decrease In Government Remittances
IncreaseDecreaseInGovernmentRemittances
usd
CY2023 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
usd
CY2023 us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
usd
CY2022 GAME Increase Decrease In Consideration Payable
IncreaseDecreaseInConsiderationPayable
usd
CY2022 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
usd
CY2022 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
usd
CY2023 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
usd
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2022 GAME Proceeds From Repayments Of Line Of Credit
ProceedsFromRepaymentsOfLineOfCredit
usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 GAME Divestiture Of Assets In Exchange For Contingent Consideration Receivable
DivestitureOfAssetsInExchangeForContingentConsiderationReceivable
usd
CY2022 GAME Shares Options And Warrants Issued For Acquisition Of Engine
SharesOptionsAndWarrantsIssuedForAcquisitionOfEngine
usd
CY2022 GAME Reclassification Warrants To Warrant Liability
ReclassificationWarrantsToWarrantLiability
usd
CY2023 GAME Warrants Issued For Credit Facility
WarrantsIssuedForCreditFacility
usd
CY2022 us-gaap Stock Issued1
StockIssued1
usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2022 us-gaap Restructuring Charges
RestructuringCharges
usd
CY2022Q4 us-gaap Goodwill
Goodwill
usd
CY2022 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GoodwillAndIntangibleAssetImpairment
CY2022Q4 GAME Accrued Convertible Debt Principal And Interest Due Current
AccruedConvertibleDebtPrincipalAndInterestDueCurrent
usd
CY2022Q4 GAME Accrued Debt Modification Fees Current
AccruedDebtModificationFeesCurrent
usd
CY2022Q4 GAME Accrued Lease Abandonment Current
AccruedLeaseAbandonmentCurrent
usd
CY2022Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
usd
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
usd
CY2022Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023 GAME Current Other Foreign Tax Expense Benefit
CurrentOtherForeignTaxExpenseBenefit
usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
usd
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2022Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P1Y
CY2022 us-gaap Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration
DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39389
CY2023 dei Entity Registrant Name
EntityRegistrantName
GAMESQUARE HOLDINGS, INC
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-1946435
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
6775 Cowboys Way
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 1335
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Frisco
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Country
EntityAddressCountry
US
CY2023 dei City Area Code
CityAreaCode
(216)
CY2023 dei Local Phone Number
LocalPhoneNumber
464-6400
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2023 dei Trading Symbol
TradingSymbol
GAME
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
27906523 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30316256 shares
CY2023 dei Auditor Firm
AuditorFirmId
6644
CY2023 dei Auditor Name
AuditorName
Kreston GTA LLP
CY2023 dei Auditor Location
AuditorLocation
Markham, Ontario, Canada
CY2023Q4 us-gaap Cash
Cash
2945373 usd
CY2022Q4 us-gaap Cash
Cash
977413 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
47465 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16459684 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8114542 usd
CY2023Q4 GAME Government Remittances
GovernmentRemittances
1665597 usd
CY2022Q4 GAME Government Remittances
GovernmentRemittances
107660 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Asset Current
BusinessCombinationContingentConsiderationAssetCurrent
207673 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
916740 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
897145 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
22242532 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
10096760 usd
CY2023Q4 us-gaap Investments
Investments
2673472 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Asset Noncurrent
BusinessCombinationContingentConsiderationAssetNoncurrent
293445 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2464633 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3001883 usd
CY2023Q4 us-gaap Goodwill
Goodwill
16303989 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18574144 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4609837 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2159693 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2495333 usd
CY2023Q4 us-gaap Assets
Assets
64711908 usd
CY2022Q4 us-gaap Assets
Assets
20203813 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23493472 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4848854 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5289149 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3180208 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
260000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
47465 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
1930028 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
1092982 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
367487 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
336229 usd
CY2022Q4 GAME Credit Facility Payable
CreditFacilityPayable
802328 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4518571 usd
CY2023Q4 GAME Warrant Liability
WarrantLiability
102284 usd
CY2023Q4 GAME Arbitration Reserve
ArbitrationReserve
428624 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36177080 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10520601 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
8176928 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1994961 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2362448 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
55096 usd
CY2023Q4 us-gaap Liabilities
Liabilities
46348969 usd
CY2022Q4 us-gaap Liabilities
Liabilities
12938145 usd
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12989128 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12989128 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6352270 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6352270 shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91915169 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49672443 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-132081 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-269053 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73420149 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42137722 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18362939 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7265668 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64711908 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20203813 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51997642 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28082009 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
38551874 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
18425393 usd
CY2023 us-gaap Gross Profit
GrossProfit
13445768 usd
CY2022 us-gaap Gross Profit
GrossProfit
9656616 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21553039 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17450879 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6481027 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7089595 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2149529 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
7024000 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
701423 usd
CY2023 us-gaap Interest Expense
InterestExpense
696028 usd
CY2022 us-gaap Interest Expense
InterestExpense
169570 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2204737 usd
CY2023 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
538354 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
-515277 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-968757 usd
CY2023 GAME Arbitration Settlement Reserve
ArbitrationSettlementReserve
1041129 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-103463 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
35273 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-971265 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-134297 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31637584 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18381656 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-55096 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-304369 usd
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-31582488 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-18077287 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
300061 usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-29841 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-31282427 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-18107128 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
13718 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-31282427 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-18120846 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-31282427 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-18107128 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
136972 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-405034 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-31145455 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-18512162 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
13718 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31145455 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18525880 usd
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.84
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-3.26
CY2023 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.03
CY2022 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.81
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.81
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.26
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.26
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11119900 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11119900 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5557690 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5557690 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
17687907 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6238377 usd
CY2022 GAME Adjustments To Additional Paid In Capital Increase Decrease In Fair Value Of Contingent Consideration
AdjustmentsToAdditionalPaidInCapitalIncreaseDecreaseInFairValueOfContingentConsideration
78522 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
96359 usd
CY2022 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
76756 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1599909 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-18107128 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7265668 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7265668 usd
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
41044000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-900818 usd
CY2023 GAME Stock Issued During Period Value For Legal Settlements
StockIssuedDuringPeriodValueForLegalSettlements
183187 usd
CY2023 GAME Stock Issued During Period Value To Settle Outstanding Amounts Payable
StockIssuedDuringPeriodValueToSettleOutstandingAmountsPayable
180727 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1735630 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
136972 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
136972 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-31282427 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18362939 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18362939 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-31282427 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-18107128 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3294015 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2306661 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
335640 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
309293 usd
CY2023 GAME Shares Issued For Legal Settlements
SharesIssuedForLegalSettlements
186560 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
40794 usd
CY2022 GAME Loss On Disposition Of Assets Held For Sale
LossOnDispositionOfAssetsHeldForSale
29841 usd
CY2023 GAME Gain Loss On Settlement Of Patent Litigation
GainLossOnSettlementOfPatentLitigation
635480 usd
CY2023 us-gaap Noncash Merger Related Costs
NoncashMergerRelatedCosts
45648 usd
CY2022 us-gaap Noncash Merger Related Costs
NoncashMergerRelatedCosts
338522 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
-515277 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-968757 usd
CY2023 GAME Gain Loss In Fair Value Of Arbitration Reserve
GainLossInFairValueOfArbitrationReserve
1041129 usd
CY2022 GAME Gain Loss In Provision For Reclamation Deposit
GainLossInProvisionForReclamationDeposit
-16895 usd
CY2023 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
538354 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2204737 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
7024000 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
701423 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
171000 usd
CY2023 GAME Change In Deferred Tax Balances
ChangeInDeferredTaxBalances
-55096 usd
CY2022 GAME Change In Deferred Tax Balances
ChangeInDeferredTaxBalances
-315548 usd
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
411789 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1735630 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1599909 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
880481 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5272960 usd
CY2023 GAME Increase Decrease In Government Remittances
IncreaseDecreaseInGovernmentRemittances
493834 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-723612 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
177628 usd
CY2022 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
4897 usd
CY2022 us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
48980 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4793223 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5653078 usd
CY2023 GAME Increase Decrease In Consideration Payable
IncreaseDecreaseInConsiderationPayable
-305648 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-358383 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
765937 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-336229 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-301355 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16078270 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11924148 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2239 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31251 usd
CY2023 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
11326146 usd
CY2023 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
2750000 usd
CY2022 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
49356 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14073907 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18105 usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6303211 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
64834 usd
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
750000 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
750000 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
185397 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
149442 usd
CY2023 GAME Proceeds From Repayments Of Line Of Credit
ProceedsFromRepaymentsOfLineOfCredit
4518571 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3953968 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6838935 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
65820 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16289 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
2015425 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
-5050819 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
977413 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6028232 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2992838 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
977413 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
561335 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
11950 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
543676 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
535148 usd
CY2023 GAME Divestiture Of Assets In Exchange For Contingent Consideration Receivable
DivestitureOfAssetsInExchangeForContingentConsiderationReceivable
501118 usd
CY2023 GAME Shares Options And Warrants Issued For Acquisition Of Engine
SharesOptionsAndWarrantsIssuedForAcquisitionOfEngine
41044000 usd
CY2023 GAME Reclassification Warrants To Warrant Liability
ReclassificationWarrantsToWarrantLiability
900818 usd
CY2022 GAME Warrants Issued For Credit Facility
WarrantsIssuedForCreditFacility
96359 usd
CY2023 us-gaap Stock Issued1
StockIssued1
367287 usd
CY2023Q4 us-gaap Cash
Cash
2945373 usd
CY2022Q4 us-gaap Cash
Cash
977413 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
47465 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2992838 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
977413 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73400000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42100000 usd
CY2023Q4 GAME Working Capital Deficiency
WorkingCapitalDeficiency
13900000 usd
CY2022Q4 GAME Working Capital Deficiency
WorkingCapitalDeficiency
400000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zHVPNIRXuGC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline"><span id="xdx_86C_zS8ebkaWQj21">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period. Management evaluates these estimates and judgments on an ongoing basis and bases its estimates on historical experience, current and expected future conditions, third-party evaluations and various other assumptions that management believes are reasonable under the circumstances. Significant estimates have been used by management in conjunction with the following: (i) valuation of warrant liabilities; (ii) valuation of convertible debt; (iii) contingent liabilities; (iv) share-based compensation; (v) assumptions used in business combinations; and (vi) testing for impairment of long-lived assets and goodwill. Actual results may differ from the estimates and assumptions used in the consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1200000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2023 GAME Share Exchange Ratio
ShareExchangeRatio
0.020655 pure
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zLgtVJDt10F4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) <span style="text-decoration: underline"><span id="xdx_862_zZy43UHiFDAg">Concentration of credit risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company places its cash and cash equivalents, which may at times be in excess of United States’ Federal Deposit Insurance Corporation insurance limits, with high credit quality financial institutions and attempts to limit the amount of credit exposure with any one institution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one customer whose revenue accounted for approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zeV6iZ8gJVbl" title="Concentration risk percentage">43</span>% of total revenue. There were no customers whose revenue was <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTBILRyZ2Zwd" title="Concentration risk percentage">10</span>% or more of the Company’s total revenue for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No customer individually accounted for more than <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHi6WdqC2fCd" title="Concentration risk percentage">10</span>% of the Company’s accounts receivable as of December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Restructuring Charges
RestructuringCharges
500000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
900000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
4000000.0 usd
CY2023Q4 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
2700000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.034 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.047 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
0 pure
CY2023 GAME Business Acqusition Fair Value Of Arbitration Reserve
BusinessAcqusitionFairValueOfArbitrationReserve
400000 usd
CY2023Q2 us-gaap Share Price
SharePrice
1.77
CY2023 GAME Arbitration Settlement Reserve
ArbitrationSettlementReserve
1000000.0 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1918250 shares
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
4 to 1 reverse stock split
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1918250 shares
CY2022 us-gaap Depreciation
Depreciation
700000 usd
CY2023 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
60790276 usd
CY2022 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
68019706 usd
CY2023 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-33224344 usd
CY2022 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-36557433 usd
CY2023 GAME Business Acquisitions Pro Forma Net Income Loss Attributable To Parent
BusinessAcquisitionsProFormaNetIncomeLossAttributableToParent
-33224344 usd
CY2022 GAME Business Acquisitions Pro Forma Net Income Loss Attributable To Parent
BusinessAcquisitionsProFormaNetIncomeLossAttributableToParent
-36611606 usd
CY2023Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
500000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4053399 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3925275 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1588766 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
923392 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2464633 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3001883 usd
CY2023 us-gaap Depreciation
Depreciation
700000 usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
25600501 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7024000 usd
CY2023 GAME Disposal Of Assets
DisposalOfAssets
-2272512 usd
CY2023Q4 us-gaap Goodwill
Goodwill
16303989 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7000000.0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24530111 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5254544 usd
CY2023Q4 GAME Finite Lived Intangible Assets Accumulated Impairment Loss
FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss
701423 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18574144 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7920865 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2609605 usd
CY2022Q4 GAME Finite Lived Intangible Assets Accumulated Impairment Loss
FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss
701423 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4609837 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2600000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1600000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3133949 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3111603 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2521555 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1631541 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
907911 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
7267585 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18574144 usd
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
700000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1257210 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1185200 usd
CY2023Q4 GAME Accrued Convertible Debt Principal And Interest Due Current
AccruedConvertibleDebtPrincipalAndInterestDueCurrent
762442 usd
CY2023Q4 GAME Accrued Debt Modification Fees Current
AccruedDebtModificationFeesCurrent
650000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
983954 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
316967 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
872387 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1540767 usd
CY2023Q4 GAME Accrued Lease Abandonment Current
AccruedLeaseAbandonmentCurrent
376959 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
386197 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
137274 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5289149 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3180208 usd
CY2021Q2 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
expiring in April 2029
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
543086 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
543086 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
265070 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
218809 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
808156 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
761895 usd
CY2023Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P5Y3M18D
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.083 pure
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
545808 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
545808 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
545808 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
545808 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
545808 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
181936 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2910976 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
548528 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2362448 usd
CY2023 GAME Convertible Debt On Acquisition Of Engine
ConvertibleDebtOnAcquisitionOfEngine
7111333 shares
CY2023 GAME Convertible Debt On Interest Expense
ConvertibleDebtOnInterestExpense
424212 usd
CY2023 GAME Interest Payments
InterestPayments
-375000 usd
CY2023 GAME Convertilbe Debt On Refinance Of Ebcd
ConvertilbeDebtOnRefinanceOfEBCD
1554737 usd
CY2023 GAME Change In Fair Value Of Convertible Debt
ChangeInFairValueOfConvertibleDebt
-538354 usd
CY2023Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
8176928 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
7050000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
7050000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
66800000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7300000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
64233526 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8579227 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
3316254 usd
CY2023Q4 GAME Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
873716 usd
CY2022Q4 GAME Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
755187 usd
CY2023Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
821893 usd
CY2023Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
621686 usd
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
196501 usd
CY2023Q4 GAME Deferred Tax Assets Organization Costs
DeferredTaxAssetsOrganizationCosts
60735 usd
CY2022Q4 GAME Deferred Tax Assets Organization Costs
DeferredTaxAssetsOrganizationCosts
79417 usd
CY2023Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
3876 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
155765 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
70128187 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9569596 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
66773972 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7264764 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3354215 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2304832 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
541895 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
820386 usd
CY2023Q4 GAME Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
-468383 usd
CY2022Q4 GAME Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
-667501 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2278174 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
815927 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-65763 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-56114 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3354215 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2359928 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
55096 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3200 usd
CY2022 GAME Current Other Foreign Tax Expense Benefit
CurrentOtherForeignTaxExpenseBenefit
7979 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11179 usd
CY2023 GAME Deferred Other Foreign Tax Expense Benefit
DeferredOtherForeignTaxExpenseBenefit
-55096 usd
CY2022 GAME Deferred Other Foreign Tax Expense Benefit
DeferredOtherForeignTaxExpenseBenefit
-315548 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-55096 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-315548 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-55096 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-304369 usd
CY2023 GAME Income Loss Before Income Taxes
IncomeLossBeforeIncomeTaxes
-31337523 usd
CY2022 GAME Income Loss Before Income Taxes
IncomeLossBeforeIncomeTaxes
-18411497 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265 pure
CY2023 GAME Expected Income Tax Benefit
ExpectedIncomeTaxBenefit
-8304444 usd
CY2022 GAME Expected Income Tax Benefit
ExpectedIncomeTaxBenefit
-4879047 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5424830 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4779977 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
443320 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
108155 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
50819 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-313454 usd
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
2330379 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-55096 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-304369 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
27300000 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
13700000 usd
CY2023 GAME State Operating Loss Carryforwards Expiration
StateOperatingLossCarryforwardsExpiration
expire beginning in 2037
CY2023 GAME Foreign Operating Loss Carryforwards Expiration
ForeignOperatingLossCarryforwardsExpiration
expire in 2037
CY2023Q1 GAME Stock Issued During Period Shares To Settle Outstanding Amounts Payable
StockIssuedDuringPeriodSharesToSettleOutstandingAmountsPayable
72409 shares
CY2023Q4 GAME Stock Issued During Period Shares To Settle Outstanding Amounts Payable
StockIssuedDuringPeriodSharesToSettleOutstandingAmountsPayable
72409 shares
CY2023Q1 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
200000 usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
200000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
6380083 shares
CY2023Q2 GAME Stock Issued During Period Shares For Legal Settlements
StockIssuedDuringPeriodSharesForLegalSettlements
29929 shares
CY2023Q2 GAME Stock Issued During Period Shares For Legal Settlements
StockIssuedDuringPeriodSharesForLegalSettlements
29929 shares
CY2023Q1 GAME Stock Issued During Period Shares Issuance Of Common Shares To Settle Contingent Consideration
StockIssuedDuringPeriodSharesIssuanceOfCommonSharesToSettleContingentConsideration
29359 shares
CY2023 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
125148 shares
CY2022 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
68250 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4161110 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1513680 shares
CY2023 GAME Share Based Compensation Arrangement By Share Based Payment Award Options Acquisition In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAcquisitionInPeriodGross
261929 shares
CY2023 GAME Share Based Compensation Arrangements By Share Based Payment Award Options Acquisition In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquisitionInPeriodWeightedAverageExercisePrice
5.15
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
12110 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.85
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
249819 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.26
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M9D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
237771 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.32
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M17D
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
5.0 usd
CY2022Q2 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2023-06-30
CY2023 us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
23000 usd
CY2023 us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
80000 usd
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1300000 usd
CY2022Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2025-08-31
CY2022Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.07 pure
CY2022Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
4.40
CY2020Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
241666 shares
CY2020Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1200000 usd
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
241666 shares
CY2020Q4 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
20.0 usd
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
241666 shares
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
241666 shares
CY2023Q2 GAME Liability For Arbitration
LiabilityForArbitration
1500000 usd
CY2022Q2 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
2100000 usd
CY2022Q2 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
1900000
CY2023 us-gaap Revenues
Revenues
51997642 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
38551874 usd
CY2023 us-gaap Gross Profit
GrossProfit
13445768 usd
CY2022 us-gaap Revenues
Revenues
28082009 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
18425393 usd
CY2022 us-gaap Gross Profit
GrossProfit
9656616 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2464633 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3001883 usd
CY2023Q4 GAME Contingent Consideration Fair Value Disclosures
ContingentConsiderationFairValueDisclosures
501118 usd
CY2023Q4 GAME Warrant Liability Fair Value Disclosures
WarrantLiabilityFairValueDisclosures
102284 usd
CY2023Q4 GAME Arbitration Reserve Fair Value Disclosures
ArbitrationReserveFairValueDisclosures
428624 usd
CY2023Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
8176928 usd

Files In Submission

Name View Source Status
0001493152-24-014809-index-headers.html Edgar Link pending
0001493152-24-014809-index.html Edgar Link pending
0001493152-24-014809.txt Edgar Link pending
0001493152-24-014809-xbrl.zip Edgar Link pending
audit_001.jpg Edgar Link pending
audit_002.jpg Edgar Link pending
ex21.htm Edgar Link pending
ex23.htm Edgar Link pending
ex23_001.jpg Edgar Link pending
ex23_002.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-2.htm Edgar Link pending
ex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
game-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
game-20231231_cal.xml Edgar Link unprocessable
game-20231231_lab.xml Edgar Link unprocessable
game-20231231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
game-20231231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable